REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Clinico Colmedicos Ips S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Laboratorio Clinico Colmedicos Ips S.A.S. Profile Updated: September 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Clinico Colmedicos Ips S.A.S. is an enterprise in Colombia, with the main office in Medellin. It operates in the Ambulatory Health Care Services industry. The company was established on October 04, 1988. There are currently 1,028 (2024) people employed by Laboratorio Clinico Colmedicos Ips S.A.S.. From the latest financial highlights, Laboratorio Clinico Colmedicos Ips S.A.S. reported a net sales revenue increase of 22.51% in 2023. Its’ total assets recorded a growth of 36.59%. The net profit margin of Laboratorio Clinico Colmedicos Ips S.A.S. decreased by 2.39% in 2023.

Headquarters
Calle 50 46 36 Piso 14 Edificio Furatena
Medellin; Antioquia;

Contact Details: Purchase the Laboratorio Clinico Colmedicos Ips S.A.S. report to view the information.

Website: http://colmedicos.com

Basic Information
Total Employees:
Purchase the Laboratorio Clinico Colmedicos Ips S.A.S. report to view the information.
Outstanding Shares:
Purchase the Laboratorio Clinico Colmedicos Ips S.A.S. report to view the information.
Incorporation Date:
October 04, 1988
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Clinico Colmedicos Ips S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
22.51%
Total operating revenue
22.51%
Operating profit (EBIT)
7.79%
EBITDA
9.02%
Net Profit (Loss) for the Period
1.88%
Total assets
36.59%
Total equity
42.64%
Operating Profit Margin (ROS)
-2.79%
Net Profit Margin
-2.39%
Return on Equity (ROE)
-17.69%
Debt to Equity Ratio
18.77%
Quick Ratio
0.17%
Cash Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?